BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20889146)

  • 1. Memory B cells from older people express normal levels of cyclooxygenase-2 and produce higher levels of IL-6 and IL-10 upon in vitro activation.
    Bancos S; Phipps RP
    Cell Immunol; 2010; 266(1):90-7. PubMed ID: 20889146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody production.
    Ryan EP; Pollock SJ; Murant TI; Bernstein SH; Felgar RE; Phipps RP
    J Immunol; 2005 Mar; 174(5):2619-26. PubMed ID: 15728468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of CD72 expression on CD19
    Lyu M; Hao Y; Li Y; Lyu C; Liu W; Li H; Xue F; Liu X; Yang R
    Br J Haematol; 2017 Jul; 178(2):308-318. PubMed ID: 28419421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mincle and human B cell function.
    Kawata K; Illarionov P; Yang GX; Kenny TP; Zhang W; Tsuda M; Ando Y; Leung PS; Ansari AA; Gershwin ME
    J Autoimmun; 2012 Dec; 39(4):315-22. PubMed ID: 22698596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.
    Wagner M; Poeck H; Jahrsdoerfer B; Rothenfusser S; Prell D; Bohle B; Tuma E; Giese T; Ellwart JW; Endres S; Hartmann G
    J Immunol; 2004 Jan; 172(2):954-63. PubMed ID: 14707068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-Like Receptor Mediated Activation of Natural Autoantibody Producing B Cell Subpopulations in an Autoimmune Disease Model.
    Erdő-Bonyár S; Rapp J; Minier T; Ráth G; Najbauer J; Czirják L; Németh P; Berki T; Simon D
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body.
    Cao Y; Gordic M; Kobold S; Lajmi N; Meyer S; Bartels K; Hildebrandt Y; Luetkens T; Ihloff AS; Kröger N; Bokemeyer C; Atanackovic D
    J Immunol Methods; 2010 Jun; 358(1-2):56-65. PubMed ID: 20302874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
    Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Toll-like receptor 9 expression by B cells from inflammatory bowel disease patients.
    Berkowitz D; Peri R; Lavy A; Kessel A
    Hum Immunol; 2013 Dec; 74(12):1519-23. PubMed ID: 24007656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 T-helper cell cytokine phenotypes and antibody response following tetanus toxoid booster immunization.
    Livingston KA; Jiang X; Stephensen CB
    J Immunol Methods; 2013 Apr; 390(1-2):18-29. PubMed ID: 23318779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-12 directly stimulates expression of IL-10 by CD5+ B cells and IL-6 by both CD5+ and CD5- B cells: possible involvement in age-associated cytokine dysregulation.
    Spencer NF; Daynes RA
    Int Immunol; 1997 May; 9(5):745-54. PubMed ID: 9184920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentially regulated expression and function of CD22 in activated B-1 and B-2 lymphocytes.
    Lajaunias F; Nitschke L; Moll T; Martinez-Soria E; Semac I; Chicheportiche Y; Parkhouse RM; Izui S
    J Immunol; 2002 Jun; 168(12):6078-83. PubMed ID: 12055217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference values for B cell subpopulations from infancy to adulthood.
    Morbach H; Eichhorn EM; Liese JG; Girschick HJ
    Clin Exp Immunol; 2010 Nov; 162(2):271-9. PubMed ID: 20854328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells: role of TGF-beta 1.
    Parekh VV; Prasad DV; Banerjee PP; Joshi BN; Kumar A; Mishra GC
    J Immunol; 2003 Jun; 170(12):5897-911. PubMed ID: 12794116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 stimulation of human peripheral B lymphocytes: distinct response from naive and memory cells.
    Fecteau JF; Néron S
    J Immunol; 2003 Nov; 171(9):4621-9. PubMed ID: 14568936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 7 and 9 defects in common variable immunodeficiency.
    Yu JE; Knight AK; Radigan L; Marron TU; Zhang L; Sanchez-Ramón S; Cunningham-Rundles C
    J Allergy Clin Immunol; 2009 Aug; 124(2):349-56, 356.e1-3. PubMed ID: 19592080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID).
    Groth C; Drager R; Warnatz K; Wolff-Vorbeck G; Schmidt S; Eibel H; Schlesier M; Peter HH
    Clin Exp Immunol; 2002 Jul; 129(1):133-9. PubMed ID: 12100033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD24(hi)CD27(+) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide.
    van der Vlugt LE; Mlejnek E; Ozir-Fazalalikhan A; Janssen Bonas M; Dijksman TR; Labuda LA; Schot R; Guigas B; Möller GM; Hiemstra PS; Yazdanbakhsh M; Smits HH
    Clin Exp Allergy; 2014 Apr; 44(4):517-28. PubMed ID: 24261983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell-activating factor enhances interleukin-6 and interleukin-10 production by ODN-activated human B cells.
    Yehudai D; Snir A; Peri R; Halasz K; Haj T; Odeh M; Kessel A
    Scand J Immunol; 2012 Oct; 76(4):371-7. PubMed ID: 22725135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy.
    Snir A; Kessel A; Haj T; Rosner I; Slobodin G; Toubi E
    Clin Exp Rheumatol; 2011; 29(4):697-700. PubMed ID: 21813064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.